Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer clinical trials

Explore recruiting psma positive non curative metastatic castration resistant prostate cancer clinical trials.

Also recruiting in Europe

Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomised, multi-centre, intra-patient imaging and dosimetry crossover study of lutetium (177Lu) rhPSMA-10.1 and lutetium (177Lu) vipivotide tetraxetan (Pluvicto®) in patients with non-curative metastatic prostate cancer

Spain, Germany, France, Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer trials by city

Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Toronto Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Vancouver Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Montreal Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Calgary Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Edmonton Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Ottawa Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Winnipeg Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Quebec City Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Hamilton Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Kitchener Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in London Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Halifax Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in New York Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Los Angeles Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Chicago Psma Positive Non Curative Metastatic Castration Resistant Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease